On December 15, the Australian Department of Health’s Therapeutic Goods Administration (TGA) announced a final decision to down-schedule certain low-dose cannabidiol (CBD) products, allowing select medicinal cannabis products to be available over the counter.
Tasmanians will be able to access medicinal cannabis without a prescription as soon as February next year, after a change to the substance’s legal status.